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STUDIES IN PORPHYRIA 
VI. Biosynthesis of Porphyrins in Mammalian Skin and in the Skin of Porphyric Patients 
DAVI.D R. BICKERS, M.D., LOUISE KEOGH, B.S., ARLEEN B. RIFKIND, M.D., LEONARD c. HARBER, M .D., 
AND ArrALLAH KAPPAS, M.D. 
Department of Dermatology, College of Physicians and Surgeons, Columbia Uniuer.~ity and the Rockefeller 
University, New York, New York , U.S. A. 
Porphyrin biosynthesis in mammalian skin and in skin obtained from patients with 
selected types of porphyria has been studied. Cutaneous poq:~hyrinogenesis required the 
precursor b-aminolevulinic acid (ALA) which, when added to murine. rat, and human skin in 
vitro. was rapidly converted to porphyrins. Total porphyrin content was quantitated by 
fluorescence assay. and spectral studies indicated that more than 80o/c of the porphyrin 
produced was protoporphyrin. The majority of skin porphyrinogenesis occurred in epidermis 
or in epidermal derivatives such as hair roots. Known inducers of hepatic b-aminolevulinic 
acid synthetase (ALAS), the rate-limiting enzyme for heme biosynthesis, were not inducers 
when added to skin in vitro. 
Skin from patients with acute intermittent porphyria demonstrated a 43% decrease in 
cutaneous porphyrin production as compared to unaffected normals. This is consistent with 
the known deficiency of uroporphyrinogen synthetase that has been previously demonstrated 
in the liver and red blood cells of these patients. Porphyrinogenesis in skin of patients with 
porphyria cutanea tarda was not different from controls. 
These studies demonstrate that skin has the enzymat.ic capacity to synthesize porphyrins 
from added ALA and thai cutaneous porphyrinogenesis from ALA is deficient in patients 
with acute intermittent porphyria. 
Porphyrins are biochemical intermediates in the 
synthesis of heme. a moiety that occurs in all living 
cells and is a basic requirement for aerobic and 
anaerobic metabolism. For example. heme is the 
prosthetic group for a number of different proteins 
including cytochromes. catalases. peroxidases, as 
well as hemoglobin. 
Heme biosynthesis is initiated in the mitochon-
drion of the cell where. in the presence of the 
enzyme b-aminolevulinic acid synthetase (ALAS). 
succinyl CoA and glycine are combined to form the 
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aminoketone b-aminoleuvulinic acid (ALA) . Early 
studies by Granick and Urata lll showed that the 
activity of this enzyme in liver is rate-limiting for 
heme synthesis, whereas the remaining enzymes in 
the pathway are usually present in sufficient non-
limiting amounts to convert any enzymatically 
for med ALA to porphyrins and/or heme (Fig. 1). 
Following the formation of ALA. additional enzy-
matic activity results in the production of porpho-
bilinogen (PBG). a monopyrrole, and subsequently 
in the formation of porphyrinogens that are tetra-
pyrroles consisting of four monopyrroles linked by 
methene bridges. With the insertion of iron into 
the tetrapyrrole pl'Otoporphyrin IX, heme is pro-
duced. Porphyrins are oxidized porphyrinogens 
and it is the latter nonresonating compounds that 
are the true intermediates of the heme pathway in 
vivo (Fig. 1). Oxidized porphyrins are fluorescent. 
Their importance in clinical dermatology relates to 
the fact that in selected types of porphyria they 
may accumulate in the kin and, following expo-
sure to certain wavelengths of light, result in 
cutaneous photosensitization [2-4]. These fluores-
cent chemicals absorb light intensely in the 
400-nm range, the so-called Soret band, and by 
transferr ing this absorbed energy to cellular struc-
tu res. photosensitizing damage can occur. Cutane-
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FIG. 1. Outline of the heme biosynthetic pathway. 
ous photosensitivity may be associated with in-
creased porphyrin levels in the skin, erythrocytes. 
and/or plasma. Furthermore. relatively simple di-
agnostic procedures can detect excessive por-
phyrins in the urine and feces of affected indi\·idu-
als [5.6]. 
The requirements for heme synthesis are great-
est in the bone marrow and in the liver. Bone 
marrow heme is used for the production of hemo-
globin in the erythrocyte. whereas hepatic heme is 
incorporated into a variety of proteins by the liver. 
Under normal circumstances the heme pathway is 
precisely controlled such that only trace amounts 
of the porphyrins are present in tissues such as 
bone marrow and liver. 
Diseases reflecting derangements in the control 
of porphyrin-heme biosynthesis, known as t he 
porphyrias, are of considerable medical interest 
since selected biochemical aberrations of heme 
synthesis can be correlated with certain clinical 
manifestations of these disorders. 
Many different tissues are known to be capable 
of porphyrin synthesis from added ALA [7 ,8]. 
However, no studies have been carr ied out to 
evaluate porphyrin biosynthesis in the skin 
although Pathak and Burnett [9,10]did quantitate 
the porphyrins present in normal rat and human 
skin, in animals with drug-induced porphyria, and 
in patients with porphyria cutanea tarda. Recent 
studies by Bonkowsky et al [11) and by Sassa et a! 
[12] have shown that by adding ALA or PBG to skin 
fibroblasts grown in tissue culture, it is possible to 
assess the activity of the enzyme uroporphyrinogen 
synthetase (UROS). This enzyme functions to 
convert PBG to uroporphyrinogen I. The activity of 
UROS has been shown to be deficient in both the 
liver and red blood cells of patients with acute 
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intermittent porphyria (AlP) [1 3-15). Affected 
individuals as well as latent carriers of this autoso-
mal dominant defect demonstrate decreased activ-
ity of UROS. No previous studies have been 
carried out to assess the feasibility of using skin 
biopsies incubated in organ culture as a method 
with which to measure this enzyme activity in pa-
tients with AlP. 
The present study was designed to assess several 
aspects of porphyrin-heme biosynthesis in the 
skin: (1) t he capacity of mammalian skin to 
convert ALA to porphyrins using an organ culture 
system; (2) the abili ty of known inducers of hepatic 
heme synthesis to induce porphyrinogenesis in 
cutaneous tissue in vitro: (3) the feasibility of using 
skin biopsies from patients with AlP to demon-
strate deficient UROS activity in cutaneous tissue. 
MATERIALS AND METHODS 
Porphyrinogenesis in skin. Skin biopsies (4- 6 mm in 
diameter) were obtained from mature male Sprague-
Dawley rats. from Swiss- Webster mice, from normal 
adult males undergoing hair transplantation. and from 
patients with AlP or porphyria cutanea tarda (PCT). 
The skin samples were finely minced with sterile scissors. 
incubated for 24 hr in standard tissue cu lture media 
using a modification of the liver cell culture technique 
described by Granick 116 J. The major modification 
involved the addition of the precursor ALA to the 
cultured skin . This was necessary because. unlike the 
liver which demonstrates relatively high levels of por-
phyrin production. the skin without added ALA synthe-
sizes practically no detectable porphyrins. 
Selected concentrations of ALA (50-500 nM) were 
added and incubation carried out at 37 ° C in a humidi-
fied atmosphere of 5o/c CO, in air. Following incubation. 
culture medium containing the minced skin was homoge-
nized in a Polytron (Brinkmann ) and then lyophilized. 
Five milliliters of l: I perchloric acid: methanol mixture 
were added to the lyophilized preparation and, following 
filtration. t he extracted samples were quantitated in a 
Hitachi MPF-:2A fluorescence spectrophotometer usin~ 
coproporphyrin as a standard. Repeated determinations 
of the fluorescence spectra of the porphyrins synthesized 
by the skin in these studies showed these to be a mixture 
of porphyrins consisting primarily of protoporphyrin. 
Therefore. data presented here are reported as pmole of 
protoporphyrin/ mg protein since this always comprised 
at least 80"« of the porphyrins produced by the skin. A 
small aliquot of the homogenized skin sample was taken 
for protein determination by the procedure of Sutherland 
et al [17] using bovine serum albumin as a standard. 
Inducibility of cutaneou.~ ALAS. In order to assess the 
inducibility of ALAS in the skin, two known inducers of 
the hepatic enzyme, allyliosopropylacetamide (AlA) and 
the 5i't-steroid, etiocholanolone, were added to organ 
cultures of skin biopsies in final concentrations ranging 
from 1.5 to 15 nM and 5 to 50 pM, respectively. They were 
then incubated for 24 hr and analyzed for por-
phyrinogenesis as described above. 
Porphyrinogenesis in the skin of patients with two 
types of porphyrw. ln these studies porphyrin production 
from added ALA was quantitated in skin obtained from 
patients with either AIP (5 patients) or P CT (6 patients). 
Four to eight biopsies (3- or 4-mm punches) were 
obtained from non-light-exposed body areas of these 
individuals and incubated in the organ culture system 
described above. 
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RESULTS 
Porphyrin. synthesis in rat and mouse skin. T he 
Sprague- Dawley rat skin specimens incubated in 
tissue cul ture medium with ALA for 24 hr showed 
linear increases in porphyrin synthesis using ALA 
up to a final concentration of 50 1-1g (300 nM) (Fig. 
2). Boiled skin to which ALA was added at final 
concen trations up to 100 1-1 g (500 nM) showed no 
significant increase in porphyrinogenes is . imi-
larly. rat skin incubated in tissue culture medium 
without added ALA demonstrated no significant 
increase in porphyrin levels over periods up lo 72 
hr. T he time course of porphyrin production from 
added ALA in rat skin is shown in F igure 3. 
Porphyrinogenesis began within 4 hr following t he 
addition of ALA and there was continuous accu-
mulation of porphyrins in a linear manner up to at 
least 16 hr . During the time of maximum por-
phyrin synthesis. removal of culture medium con-
taining ALA and replace ment with ordinary me-
dium resulted in cessation of porphyrinogenes is. 
Porphyrin synthesis in mouse skin . .. kin biopsie 
obtained from wiss- Webster mice also demon-
st rated the accumulation of porphyrins in a linear 
manner up to a final concentration of 300 n M of 
added ALA. Boiled skin with ALA, and skin 
specimens incubated in the absence of ALA. 
showed no significant porphyrinogenesis. 
Porphyrin s:vnthesis in human skin. Skin biopsies 
obtained from the scalps of males undergoing hair 
transplantation as well as the gluteal areas of 
norm al individuals showed maximum por-
phyrinogene. is following the addition of ALA in 
concentrations identical to those that produced 
maximum porph~· rinogene is in rat and mouse skin 
(Fig. 4). This suggests that there a re some si mila ri-
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FIG. 2. Porphyrinogenesis in rat skin from added 
ALA . Skin samples were incubated for 24 hr with the 
concentrations of ALA shown and porphyrins quantitat-
ed as described in Materials and Methods. 
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F IG. 3. Time course of porphyrinogenesis in rat skin 
from added ALA (100 ~g). kin samples were incubated 
for the time intervals shown and porphyrins quantitated 
as described in Materials and Methods. 
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FIG. 4. Porphyrinogenesis in human skin from added 
ALA. kin biopsies were incubated with ALA for 24 hr 
and porphyrins quantitated as described in Materials 
and Methods. 
ties among the activities of the porphyrin-heme 
pathway in the skins of these different species. 
Flourescent microscopy of snap-frozen sections 
of skin biopsies following incubation with ALA 
demonstrated brilliant reddish pink fluorescence, 
indicative of porphyrins, to be pre ent primarily in 
the epidermis or in epidermal derivatives such as 
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hair roots. This suggests that, under the conditions 
utilized in these in vitro experiments. the epider-
mis was the major site of cutaneous por-
phyrinogenesis. These data do not preclude the 
possibility that porphyrins synthesized in dermal 
components could subsequently have diffused into 
the epidermis. 
Induction of porphyrinogenesis in rat and 
human skin. Addition of the hepatic porphyrino-
genic drug AlA to a final concentration up to 15 nM 
or the 5.8-steroid etiocholanolone in a final concen-
tration up to 50 ~M to the culture medium failed to 
elicit any greater porphyrinogenesis as compared 
to controls in rat and human skin samples. Our 
previous studies have shown that trace amounts of 
AlA or etiocholanolone will elicit enhanced por-
phyrinogenesis in chick embryo liver cells using 
Sassa and Granick's in vitro system [18]. These 
data indicate that chemical agents known to 
induce heme synthesis either in the liver or in the 
bone marrow have no demonstrable effect in the 
skin under the conditions of these experiments. 
Porphyrinogenesis in the skin of patients with 
AlP and PCT. An attempt was made to confirm 
recent reports suggesting that there is decreased 
porphyrin production from precursors in cultured 
skin fibroblasts obtained from patients with AIP 
[11,12 ]. Skin biopsies were obtained from normal 
individuals and from patients with AlP and PCT. 
The results of these studies are shown in FigUie 5. 
The mean value ± SE for porphyrin production 
from a final concentration of 500 nM ALA by 
human skin in 6 normal individuals was 41.6 ± 5.2 
pmole protoporphyrin/ mg skin protein. Studies of 
skin biopsies from 4 of 5 patients with AlP demon-
strated a marked decrease in porphyrinogenesis t.o 
a mean value of 23.4 ± 5.9 pmole protoporphyrin/ 
mg protein. a decrease of 43'lt as com pared to the 
normal controls. 1n contrast, skin obtained from 
patients with PCT demonstrated consistently 
higher basal skin porphyrin \eve\s as well as higher 
total accumulation of porphyrins when compared 
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Frc. 5. Porphyrinogenesis in skin of normal individu-
als and patients with AlP and PCT. Skin biopsies were 
incubated with ALA and porphyrins quantitated as 
described in Materials and Methods. 
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to those from normals and patients with AlP 
following the addition of ALA. 
DISCUSSION 
The studies presented here indicate that mam-
malian skin has the enzymatic capacity to synthe-
size porphyrins in vitro provided that the substrate 
ALA is added to the tissue. This suggests that ALA 
formed by ALAS is rapidly converted to porphyrins 
and/or heme by enzymes of the heme pathway 
present in skin. Our data suggest the intriguing 
possibility that, by whatever mechanism, excessive 
porphyrin production in the skin itself could con-
tribute to the elevated prophyrin levels found in 
patients with selected types of photosensitizing 
porphyria. It should be stressed that there is no 
unequivocal evidence for the role of skin por-
phyrinogenesis in cutaneous porphyria at the pres-
ent time though it has been reported that intrave-
nous infusions of ALA into human subjects resulted 
in mild cutaneous photosensit ivity 1191. 
Agents known to induce ALAS activity in the 
liver such as AlA and the 5{j-steroid etiocholano-
lone had no detectable effect on porphyrinogenesis 
in rat and human skin . This indicates that t he 
enzyme is not inducible in the skin at least under 
the conditions of these studies. It is reasonable to 
assume that there is only a small amount of 
inducible ALA activity in the skin. since cutane-
ous tissue does not appear w require the large 
amounts of heme needed by other tissues such as 
liver or bone marrow. 
Bonkowsky et al lll) have postulated that there 
may be a n .. irreversible'' type of repression of 
ALAS in most extrahepatic tissues of both normal 
and porphyric subjects. This would render the 
enzyme in such tissues relatively incapable of 
responding to exogenous drugs or chemicals. Our 
data in skin are consis tent with that hypothesis. 
Although these studies failed to demonstrate 
inducibility of ALA in rat skin. it is clear from 
previous studies that drug metabolizing enzyme 
activity and the heme-protein cytochrome P-450 
a re inducible in the skin [20,21 ]. In particular. 
cutaneous ary l hydrocarbon hydroxylase, an 
enzyme which functions in the metabolism of 
polycyclic hydrocarbon carcinogens . is inducible 
(10- to 20-fold) in both rat and human skin 
following topical application of selected chem ical 
agents or following incubation with the inducers in 
vitro [22,23]. This indicates that additional heme-
protein synthesis must occur in the skin despite 
the fact that measurable increases in ALAS activ-
ity could not be detected in our in vitro system. 
Studies by DeMatteis and Gibbs [24.] in rat liver 
have shown that the drug phenylbutazone can 
cause an increase in hepat ic P-450 without any 
detectable increase in ALAS activity. There may 
he a poo\ of preformed heme present which could 
combine with the apo-protein for production of the 
complete heme-protein (in t his instance cyto-
c hrome P-450). Thus. control of heme-protein 
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production in the skin may be dependent upon 
both limited ALAS activity and a pool of heme 
available for the production of heme-proteins. 
Recent studies in the genetic disease AlP have 
shown that t here is a deficiency of UROS, an 
enzyme which fun ctions in the conversion of the 
monopyrrole PBG to the tetrapyrrole uropor-
phyrinogen I (URO I). This enzyme deficiency in 
AlP accounts for the excessive levels of plasma and 
urinary ALA and PBG found in these patients. 
Skin fibroblasts of patients with AlP grown in 
tissue culture demonstrate deficient UROS activ-
ity [13, 14] as com pared t o normal individuals. 
Data presented in t his paper have shown a pro-
nounced decrease in porphyrin synt hesis by the 
skin of patients with AlP following the addition of 
ALA in vitro. Our data indicate that t here is an 
almost 50% decrease in cutaneous porphyrinogene-
sis in skin biopsies of patients with AlP incubated 
in short-term organ culture. Studies are currently 
under way to assess the feasibility of measuring 
porphyrinogenesis from added PBG in skin since 
this would provide a more direct assessment of 
cutaneous URO activity. 
These studies have demonstrated t hat t here is 
enzymatic activity in the skin capable of por-
phyrinogenesis from added ALA. In addition. by 
using a relatively s imple organ culture procedure, 
it is possible to detect decreased porphyrinogene-
sis in t he skin of patients with AlP which is most 
like!:-· due to the UROS deficiency that has been 
identified in these indi\·iduals. Our findi ngs reem-
phasize the fact that metabolic activity present in 
the skin makes this readily available tissue emi-
nently suitable for the assessment of gene defects 
in human populations. 
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